BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Enzyme Immunoassay, Fetal Fibronectin

    PMA: P920048 · Supplement: S001 · Decision Jan 8, 1997
    View on FDA
    Classifications
    1
    FEI Numbers
    4
    Registration Numbers
    4

    Basic Information

    Device Name
    Enzyme Immunoassay, Fetal Fibronectin
    Trade Name
    ADEZA FETAL FIBRONECTIN EIK
    PMA Number
    P920048
    Supplement Number
    S001
    Device Class
    FDA Class 3
    Product Code
    LKV
    Generic Name
    ENZYME IMMUNOASSAY, FETAL FIBRONECTIN
    Medical Specialty
    Unknown
    Advisory Committee
    Clinical Chemistry
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    January 8, 1997
    Date Received
    June 26, 1996
    Supplement Type
    Normal 180 Day Track
    Supplement Reason
    Labeling Change - Indications/instructions/shelf life/tradename
    Expedited Review
    N

    Advisory Committee Statement

    APPROVAL FOR A MODIFICATION OF THE INTENDED USE STATEMENT AS FOLLOWS: "THE DEVICE IS FURTHER INDICATED FOR USE IN CONJUNCTION WITH OTHER CLINICAL INFO AS AN AID IN ASSESSING THE RISK OF PRETERM DELIVERY IN < 34 WEEKS, 6 DAYS WHEN A CERVICOVAGINAL SAMPLE IS OBTAINED DURING A ROUTINE PRENATAL VISIT BETWEEN 22 WEEKS, 0 DAYS AND 30 WEEKS, 6 DAYS OF GESTATION IN WOMEN WITH A SINGLETON GESTATION. THE POSITIVE PREDICTIVE VALUE RANGES FROM 13.3% TO 31.7% FOR DELIVERY IN < 34 WEEKS, 6 DAYS AND REPRESENTS AN APPROXIMATE 4- TO 7-FOLD INCREASE IN RISK OVER THE RELIABILITY OF PREDICTING DELIVERY GIVEN NO TEST INFO. THE NEGATIVE PREDICTIVE VALUE RANGES FROM 96.4% TO 97.9% MAKING IT HIGHLY LIKELY THAT DELIVERY WILL NOT OCCUR IN THESE TIME FRAMES."

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    LKV Enzyme Immunoassay, Fetal Fibronectin